Rare diseases
Investigational molecules
Locations
379 conditions with trials, the busiest first
1 276 trials across Europe, recruiting first
Study on the Effectiveness and Safety of LTP001 for Patients with Idiopathic Pulmonary Fibrosis
CzechiaStudy on the Effects of Bexotegrast for Patients with Idiopathic Pulmonary Fibrosis
BelgiumStudy on the Safety and Effectiveness of Inhaled Imatinib (AV-101) for Patients with Pulmonary Arterial Hypertension (PAH)
AustriaStudy Comparing Ociperlimab and Tislelizumab with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer
FranceStudy on Osimertinib and Drug Combination for Adults with Unresectable Non-small Cell Lung Cancer
SpainStudy on Brigatinib for Patients with ALK+ Non-Small Cell Lung Cancer
SpainLong-Term Safety Study of Inhaled Imatinib for Patients with Pulmonary Arterial Hypertension
AustriaStudy on the Effects of Dexpramipexole for Adolescents and Adults with Severe Eosinophilic Asthma
AustriaStudy on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma
CzechiaStudy of adagrasib in elderly patients (70 years or older) or patients with poor performance status who have KRAS G12C mutation-positive non-small cell lung cancer
BelgiumStudy on the Effects of Benralizumab on Lung Function in Patients with Severe Eosinophilic Asthma
DenmarkStudy on Skin Care for Patients with Advanced EGFR-Mutated Lung Cancer Treated with Amivantamab and Lazertinib
FranceThe therapies tested most often in Respiratory, thoracic and mediastinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
